DMAADrugs Made In America Acquisition Corp.
10.60USD-0.09%Mkt Cap: 257.21M USDP/E: 52.98Last update: 2026-06-01
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business …
Industry Peers
Shell CompaniesIndicators:|
Key Statistics
Company
Market Cap257.21M USD
Enterprise Value356.89M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)5.94M USD
Revenue/Share—
Last Price10.60 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryUS
SectorFinancial Services
IndustryShell Companies
ISIN—
Valuation
P/E (Trailing)52.98
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-49.35
EPS (TTM)0.20
EPS (Forward)—
52W Range
10.1398% of range10.61
52W High10.61 USD
52W Low10.13 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE2.55%
ROA2.48%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-539.19K USD
CapEx (TTM)—
FCF Margin—
FCF Yield-0.59%
Net Debt-6.14K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio0.03
Quick Ratio0.02
Book Value/Sh-0.2150 USD
Cash/Share0.0000 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.24.28M
Float27.31M
Insiders18.49%
Institutions98.23%
Short Interest
Short Ratio0.4d
Short % Float0.36%
Short % Out.0.31%
Shares Short103.81K
Short (prev mo.)17.25K
Technical
SMA 5010.55 (+0.5%)
SMA 20010.40 (+1.9%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)73.90K
Avg Vol (10d)52.76K
Technical Indicators
RSI (14)62.2
MACD0.0153
MACD Signal0.0173
MACD Hist.-0.0020
BB Upper10.62 USD
BB Middle10.59 USD
BB Lower10.57 USD
BB Width0.44%
ATR (14)0.0156 USD
Vol Ratio (20d)0.01x